110 Canal St., 4th Floor
-
Enabling effective therapeutic intervention for infectious diseases with a novel class of rapid, simple and inexpensive diagnostics.
-
Gel4Med is a developmental stage company focused at utilizing its biosynthetic materials platform technology as a first-in-class modality in solving unmet clinical needs for soft tissue repair and regenerative medicine. In 2023, the company anticipates launching its first clinical stage product line directed at biosurgery in wound care.
-
Pykus Therapeutics is a medical device company developing a revolutionary biodegradable, retinal sealant designed to allow patients to recover from surgery without facedown positioning or blurred vision.
-
Versatope is developing a universal influenza vaccine and cancer therapeutics by using recombinant extracellular transport vesicle (RET-Vs) technology.
-
Young BioPharma is a unique nature-based drug discovery company dedicated to fighting opioid crisis and discovering safe and efficacious non-opioid medicines for chronic pain treatment.
-
Amorphex is in clinical stage development of our topical ophthalmic drug delivery platform to replace eye drops for diseases such as glaucoma and myopia.
-
Tandem Repeat uses synthetic biology to deliver sustainable, non-polluting fibers and coatings for industries from fashion to filtration.
-
Corti Therapeutics is a seed-stage biotechnology company focusing on developing the next generation of lipid nanoparticle technology for selective and efficient extrahepatic delivery. Our technology has tunable cell selectivity and high developability. We are founded by industry leaders. -
Canal Biosciences specializes in NGS Product Development with focuses on liquid biopsy and precision medicine. -
Akeyna is a pre-clinical stage medical device company with technology invented by renowned dermatologists and scientists at Mass General Hospital in Boston. Our unique smart needle detects blood vessels in vivo to prevent severe complications such as blindness, which can occur when blood vessels are accidentally injected with dermal fillers. Akeyna's product is a fully integrated and inexpensive smart needle, used for accurate, real-time detection of blood vessels. It's so small it can easily be fastened onto any standard syringe. Our platform technology can also be utilized in numerous other clinical applications.
Wannalancit Mills, 600 Suffolk St Suite 250
-
Ending medicines fifty-year search for a regenerative bone adhesive, RevBio plans to transform the field of bone repair.
-
Advanced Silicon Group is a working to commercialize silicon nanowire biosensors in order to improve the health and medical care of all people.
-
Cx Therapeutics is developing a medical device for cervical insufficiency, which is a serious complication of pregnancy leading to preterm birth. -
Develop natural and sustainable solutions to improve animal health to better nourish and provide food security to the people on our planet... at fraction of the cost.
-
EnVision Endoscopy is a medical device startup dedicated to addressing the clinical needs for endoscopic surgeries with innovative solutions. Their mission is to provide best solution that helps patients, providers, payers, and policymakers. With a track record of innovation and launching innovative medical devices, their team is dedicated to improve patient’s lives and reduce cost of healthcare with less invasive endoluminal endoscopic procedures.
-
myBiometry is developing a life changing solution for people with asthma that can identify risk of an attack up to 20 days before it happens.
-
Thoreau Lab for Global Health (TLGH) leverages novel research concepts like biological altruism and biosocial medicine to address complex global health challenges. The organization also prioritizes training the next generation of global health leaders.
-
Enquyst Technologies is a biotechnology company that is disrupting the way that biological drugs are manufactured. We have developed next-generation biomanufacturing technology solutions to enable continuous manufacturing and to give the growing diversity of life-changing and curative treatments a viable path to the clinic with affordable costs.